Michelle Robertson - Jun 6, 2024 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Financial Officer
Signature
/s/ Scott A. Samuels for Michelle Robertson
Stock symbol
GERN
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:10 PM
Previous filing
Mar 13, 2024
Next filing
Jun 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (Right to Buy) Award $0 +250K $0.00 250K Jun 6, 2024 Common Stock 250K $2.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on September 25, 2023 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.